Vicore Pharma Holding AB (publ) (STO:VICO)
Sweden · Delayed Price · Currency is SEK 10.26
+0.12 (1.18%)
Sep 22, 2026, 5:29 PM CET
Vicore Pharma Holding AB Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Vicore Pharma Holding AB stock has a consensus rating of "Strong Buy" and an average price target of kr 26.92. The average 1-year stock price forecast is 162.38% higher than the current stock price, while the lowest is kr 15.00 (+46.20%) and the highest is kr 38.00 (+270.37%).
Price Target: kr 26.92 (+162.38%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Aug 21, 2026.
Analyst Ratings
The average analyst rating for Vicore Pharma Holding AB stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 4 | 4 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 5 | 5 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Buy Reiterates kr 38.00 | Buy | Reiterates | kr 38.00 | +270.37% | Aug 21, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates kr 33.00 | Buy | Initiates | kr 33.00 | +221.64% | Jun 9, 2026 |
Financial Forecast
Revenue This Year
8.38M
from 3.82M
Increased by 119.57%
Revenue Next Year
51.03M
from 8.38M
Increased by 508.89%
EPS This Year
-1.86
from -1.99
EPS Next Year
-1.51
from -1.86
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SEK.